Safety and Efficacy of Belzutifan in Preoperative Preparation for Patients With Pheochromocytoma/Paraganglioma (PPGL)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
It is preliminarily clarified that belzutifan exerts an inhibitory effect on catecholamine synthesis in pheochromocytoma and paraganglioma (PPGL), and its safety is simultaneously confirmed, thereby providing preliminary experimental results for the further exploration of belzutifan as a perioperative preparation drug for patients with PPGL.
Epistemonikos ID: 2d34749dbfc1b054219889cde41c17f4aeebd109
First added on: Oct 31, 2026